Entity
Description
  • Value proposition

    Pioneers in nanotechnology-based cancer treatment

    MagForce is forging new paths to treat cancer successfully and gently.

    With NanoTherm® Therapy System (NTTS), we have developed an innovative approach based on nanotechnology, which we want to make available to patients worldwide. And we are getting closer and closer to this goal. NTTS is the first and only nanotechnology-based therapy with European approval for treating recurrent Glioblastoma, a deadly brain tumor. To date, many patients diagnosed with Glioblastoma tumors have improved their quality of life after using our technology.

    Nanomedicine, Oncology, Brain Tumor, Nanotechnology, Glioblastoma, Prostate Cancer, Medical Devices, Medical Technology, and Thermotherapy

  • MagForce NT GmbH – The Nanomedicine Company

    The NanoTherm® Therapy System Gentle, focal treatment of glioblastoma Our therapy system The NanoTherm® Therapy System Gentle, focal treatment of glioblastoma Fighting cancer from the inside The NanoTherm® Therapy System (NTTS) is a set of

  • https://magforce.de/
Corporate interactions BETA
Corporate TypeTweets Articles
Deutsche Börse
Deutsche Börse
Finance, Financial Services
Deutsche Börse
Finance, Financial Services
Other

27 Nov 2018


Similar entities
Loading...
Loading...
Social network dynamics